These medications can make a big difference for some people, but they are not the answer for everyone
The top dose produced 20.9% average weight loss over 72 weeks and 20.2% in a direct comparison with semaglutides 13.7%. Its second receptor, GIP, separates tirzepatide from approved single-receptor GLP-1 drugs and helps explain the larger population-level weight loss. That 20.9% came from participants averaging about 105 kg at a BMI of 38, most of whom were sedentary
Stop taking Saxenda and contact your doctor immediately if you develop persistent severe abdominal pain, which may radiate to your back, with or without vomiting
The majority of QIs was reduced back to the respective parent compound (50% of AQ-QI and 80% of DEAQ-QI), presumably by the action of endogenous antioxidants and/or reductases, e.g., quinone reductases ( Figure 5B )
This places it in the same category as many research peptides, available through certain channels but without official sanction for human use